文献速递颈动脉与弓上血管

仅住院结局会低估颈动脉支架术后30天主要不良事件发生率

In-hospital outcomes alone underestimate rates of 30-day major adverse events after carotid artery stenting.
PubMed 文献 · J Vasc Surg · 2020-02-13

该回顾性研究利用ACS NSQIP靶向数据库分析2011至2017年899例颈动脉支架术(CAS)患者,发现仅报告住院结局的卒中/死亡率为2.7%,显著低估30天卒中/死亡率4.0%;35%的卒中/死亡、73%的死亡发生在出院后。症状性患者出院后卒中/死亡比例高于无症状患者(47% vs 27%,P < .001)。

要点

  • CAS术后仅统计住院结局会显著低估30天卒中/死亡风险。
  • 出院后事件占比高:35%卒中/死亡、73%死亡发生在出院后。
  • 症状性患者出院后卒中/死亡比例更高,需加强出院后监测。

核心结论

  • CAS和CEA术后超过四分之一的围手术期卒中发生在出院后。
  • CAS术后症状性患者出院后死亡比例更高,可能反映治疗人群风险更高。

研究设计与样本

  • 回顾性队列研究,使用ACS NSQIP靶向数据库纳入2011至2017年899例接受CAS的患者。
  • 主要结局为30天卒中/死亡,并按住院期间和出院后发生进行分层。

主要发现

  • 仅报告住院结局的卒中/死亡率为2.7%,而30天卒中/死亡率为4.0%。
  • 35%的卒中/死亡、27%的卒中、73%的死亡、35%的心脏事件及35%的卒中/死亡/心脏事件发生在出院后。
  • 症状性患者出院后卒中/死亡事件比例高于无症状患者(47% vs 27%;P < .001)。
  • CAS术后发生出院后卒中/死亡的患者术后住院时间短于住院期间发生事件者(1 [1-2] vs 5 [3-10] 天;P < .001)。
  • COPD与CAS术后出院后卒中/死亡独立相关(OR 4.4;95% CI 1.2-16;P = .02);非白人种族与30天卒中/死亡独立相关(OR 3.4;95% CI 1.4-7.9;P < .01);他汀使用与30天内无卒中/死亡相关(OR 0.5;95% CI 0.2-1.0;P = .049)。

临床怎么用

  • 评估CAS质量时应纳入出院后30天事件,而非仅依赖住院数据。
  • 对症状性患者及合并COPD者应加强出院后随访和监测。

局限性

  • 回顾性研究设计可能引入选择偏倚。
  • 需进一步研究阐明出院后卒中的原因以制定降低并发症的方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Outcome studies using databases collecting only hospital discharge data underestimate morbidity and mortality because of failure to capture postdischarge events. The proportion of postdischarge major adverse events is well characterized in patients undergoing carotid endarterectomy (CEA) but has yet to be characterized after carotid artery stenting (CAS). METHODS: We retrospectively reviewed all patients undergoing CAS from 2011 to 2017 using the American College of Surgeons National Surgical Quality Improvement Program procedure targeted database to evaluate rates of 30-day major adverse events, stratified by in-hospital and postdischarge occurrences. The primary outcome was 30-day stroke/death. Multivariable analysis using purposeful selection was used to identify independent factors associated with in-hospital, postdischarge, and 30-day stroke/death events. RESULTS: Of the 899 patients undergoing CAS, reporting of in-hospital outcomes alone would yield a stroke/death rate of 2.7%, substantially underestimating the 30-day stroke/death rate of 4.0%. In fact, 35% of stroke/deaths, 27% of strokes, 73% of deaths, 35% of cardiac events, and 35% of stroke/death/cardiac events occurred after discharge. More postdischarge stroke/death events occurred after treatment of symptomatic compared with asymptomatic patients (47% vs 27%; P < .001). During this same study period, the 30-day stroke/death rate after CEA was 2.6%, with similar proportions of postdischarge strokes (28% vs 27%; P = .51) compared with CAS but lower proportions of postdischarge deaths (55% vs 73%; P < .001). After CAS, patients experiencing postdischarge stroke/death events had a shorter postoperative length of stay compared with patients with in-hospital stroke/death (1 [1-2] vs 5 [3-10] days; P < .001). Chronic obstructive pulmonary disease was independently associated with postdischarge stroke/death (odds ratio [OR], 4.4; 95% confidence interval [CI], 1.2-16; P = .02) after CAS. Nonwhite ethnicity was independently associated with overall 30-day stroke/death (OR, 3.4; 95% CI, 1.4-7.9; P < .01), whereas statin use was associated with not having stroke/death within 30 days (OR, 0.5; 95% CI, 0.2-1.0; P = .049). CONCLUSIONS: More than one-quarter of perioperative strokes occur following discharge after both CAS and CEA. A higher proportion of postdischarge deaths occur after CAS in symptomatic patients, which may reflect treatment of a population of higher risk patients. Further investigation is needed to elucidate the cause of postdischarge stroke to develop methods to reduce these complications.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Liang P, Solomon Y, Swerdlow NJ, et al. In-hospital outcomes alone underestimate rates of 30-day major adverse events after carotid artery stenting. J Vasc Surg. 2020. PMID: 32063441. doi:10.1016/j.jvs.2019.06.201

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。